Study: X-Ray Mammography Is Accelerating Cancer Epidemic

radiationSean Adl-Tabatabai – A growing body of research now suggests that x-ray mammography is accelerating the cancer epidemic in the western world.

In 2006, a paper published in the British Journal of Radiobiology, entitled “Enhanced biological effectiveness of low energy X-rays and implications for the UK breast screening programme,” revealed the type of radiation used in x-ray-based breast screenings is much more carcinogenic than previously thought:

Recent radiobiological studies have provided compelling evidence that the low energy X-rays as used in mammography are approximately four times – but possibly as much as six times – more effective in causing mutational damage than higher energy X-rays. Since current radiation risk estimates are based on the effects of high energy gamma radiation, this implies that the risks of radiation-induced breast cancers for mammography X-rays are underestimated by the same factor. Continue reading

Chemotherapy Found to Spread Cancer [Video]

Mike Adams – New research conducted at the Albert Einstein College of Medicine of Yeshiva University has found that chemotherapy spreads cancer throughout the body, causing a sharp increase in cancer cells circulating throughout the body (including the lungs).

Led by Dr. George Karagiannis, the research focused on chemotherapy “treatment” of breast cancer, but further studies plan to see how chemotherapy might also spread cancers of other tissues, too.

The research was published in Science Translational Medicine and is entitled Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism.

A summary of the study reports that “the authors discovered that several types of chemotherapy can increase the amounts of TMEM complexes and circulating tumor cells in the bloodstream.” Continue reading

Breast Cancer Survivors Complain Of Drug Side Effects, Consider Stopping Treatment

NaturalNews February 9 2013

BreastBreast cancer survivors in online message boards complain regularly about the side effects associated with post-treatment (adjuvant) therapies, and often confess that they are considering ceasing their treatment, according to a study conducted by researchers from the University of Pennsylvania and published in the journal Pharmacoepidemiology and Drug Safety.

The researchers were interested in a class of medications known as aromatase inhibitors (AIs), some of the most common drugs given to prevent recurrence among postmenopausal women in recovery from hormone-receptor positive breast cancer.

In part, due to potentially severe side effects, just under 50 percent of all women who are prescribed the drugs, fail to complete the full prescribed course.

To find out how women who survive breast cancer actually feel about AIs, the researchers analyzed 25,256 message board posts on 12 websites popular with breast cancer survivors, including breastcancer.org, Susan G. Komen for the Cure, and Oprah.com.

“Both the availability and anonymity provided by message boards – and increasingly, other forms of social media such as Twitter and Facebook – offer patients a place to voice concerns and connect with an audience of peers in similar situations,” lead author Jun J. Mao said. “This type of social support can be very valuable to patients who are struggling with side effects.”

Pain complaints most common

Continue reading